Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 7/20 | 1.00 |
| ▸ | PPARD | Q03181 | 6/20 | 1.00 |
| ▸ | PPARA | Q07869 | 6/20 | 1.00 |
| ▸ | F7 | P08709 | 5/20 | 1.00 |
| ▸ | F3 | P13726 | 5/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 3/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 3/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 1.00 |
| ▸ | ESR1 | P03372 | 1/20 | 1.00 |
| ▸ | SRD5A2 | P31213 | 1/20 | 1.00 |
| ▸ | CASP6 | P55212 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.96 |
| ▸ | FABP4 | P15090 | 4/20 | 0.96 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.96 |
| ▸ | LMNA | P02545 | 3/20 | 0.96 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.96 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.96 |
| ▸ | NR4A2 | P43354 | 3/20 | 0.96 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.96 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.96 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gamolenic Acid SCHEMBL6686744 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAF7F3 | |
| Gamolenic Acid SCHEMBL154896 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAF7F3 | |
| Gamolenic Acid SCHEMBL6686740 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL16685439 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAF7F3 | |
| Gamolenic Acid SCHEMBL16637145 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL25316078 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL15902383 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL2852855 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAF7F3 | |
| Gamolenic Acid SCHEMBL604875 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL7552065 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAF7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025234951-A1 | PROCESS FOR THE PRODUCTION OF POLYURETHANE CATALYST | EGE Kimya San. ve Tic. A.S. (TR) | 2025-11-13 | — | — | WO | claimed |
| EP-4642830-A1 | (METH)ACRYLATED ISOCYANURATE MIXTURE, PROCESS FOR PREPARING SAME, AND USES THEREOF | ARKEMA France (FR) | 2025-11-05 | — | — | EP | claimed |
| US-20250145823-A1 | FOAM-FORMING COMPOSITIONS CONTAINING A METAL CARBOXYLATE CATALYST, RELATED FOAMS AND METHODS FOR THEIR PRODUCTION | COVESTRO LLC | 2025-05-08 | — | — | US | claimed |
| WO-2024141286-A1 | (METH)ACRYLATED ISOCYANURATE MIXTURE, PROCESS FOR PREPARING SAME, AND USES THEREOF | ARKEMA FRANCE (FR) | 2024-07-04 | — | — | WO | claimed |
| CN-116194768-A | Application of ultra-fast gas-phase electronic nose in fatty acid detection | 佳禾食品工业股份有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-113773654-A | Antibacterial material and preparation method thereof | 河南迪怡疗护科技开发有限公司 | 2021-12-10 | — | — | CN | claimed |
| CN-113583454-A | Antibacterial medical material and antibacterial medical instrument | 河南迪怡疗护科技开发有限公司 | 2021-11-02 | — | — | CN | claimed |
| CN-112996500-A | Compositions and methods for modulating ELOVL2 | 优美佳生物技术有限公司 | 2021-06-18 | — | — | CN | claimed |
| EP-3806840-A1 | COMPOSITION AND METHODS FOR MODULATION OF ELOVL2 | Youhealth Biotech, Limited (KY) | 2021-04-21 | — | — | EP | claimed |
| EP-1891189-B1 | CONCENTRATION OF FATTY ACID ALKYL ESTERS BY ENZYMATIC REACTIONS WITH GLYCEROL | EPAX NORWAY AS (NO) | 2020-09-23 | — | — | EP | claimed |
| WO-2003089399-A1 | IMPROVEMENTS IN OR RELATING TO SEPARATION TECHNOLOGY | INDUSTRIAL RESEARCH LIMITED (NZ) | 2003-10-30 | — | — | WO | claimed |
| EP-0782827-B1 | USE OF A BALANCING AGENT FOR OMEGA-6 AND OMEGA-3 UNSATURATED FATTY ACIDS | SUNTORY LTD (JP) | 2003-10-01 | — | — | EP | claimed |
| US-20030144353-A1 | Functional acylglycerides | NATURAL ASA (NO) | 2003-07-31 | — | — | US | claimed |
| WO-2003043972-A2 | FUNCTIONAL ACYLGLYCERIDES | NATURAL AS (NO) | 2003-05-30 | — | — | WO | claimed |
| WO-2003035051-A2 | THE USE OF PROTON SEQUESTERING AGENTS IN DRUG FORMULATIONS | INHALE THERAPEUTIC SYSTEMS, INC. (US) | 2003-05-01 | — | — | WO | claimed |
| EP-0965578-B1 | Novel triglyceride and composition comprising the same | SUNTORY LTD (JP) | 2003-04-16 | — | — | EP | claimed |
| WO-2003005628-A2 | GENERATING, VIEWING, INTERPRETING, AND UTILIZING A QUANTITATIVE DATABASE OF METABOLITES | LIPOMICS TECHNOLOGIES, INC. (US) | 2003-01-16 | — | — | WO | claimed |
| US-6248909-B1 | STRUCTURE OF THE HUMAN BREAST MILK TYPE, WHICH TRIGLYCERIDE HAS A SATURATED FATTY ACID HAVING 16-18 CARBON ATOMS AT THE POSITION 2, AND UNSATURATED ACYL AT THE POSITION 1 AND/OR 3 | SUNTORY LIMITED (JP) | 2001-06-19 | — | — | US | claimed |
| EP-0965578-A1 | Novel triglyceride and composition comprising the same | SUNTORY LIMITED (JP) | 1999-12-22 | — | — | EP | claimed |
| US-5948451-A | Method of modifying the balance of omega unsaturated fatty acids using a dioxabicyclo octane derivative | SUNTORY LIMITED (JP) | 1999-09-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030144353-A1 | Functional acylglycerides | ELOVL3, CPT1B, ELOVL6 | PPARG 67/4885PPARD 251/4885PPARA 120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.